CAMBRIDGE, Mass., Sept. 20, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, today announced its observance and support of the first National Familial Hypercholesterolemia (FH) Awareness Day being held today on September 20, 2012.
